Carl Zeiss Meditec AG
XETRA:AFX

Watchlist Manager
Carl Zeiss Meditec AG Logo
Carl Zeiss Meditec AG
XETRA:AFX
Watchlist
Price: 50.3 EUR 3.2% Market Closed
Market Cap: 4.5B EUR

Carl Zeiss Meditec AG
Inventory

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Carl Zeiss Meditec AG
Inventory Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Inventory CAGR 3Y CAGR 5Y CAGR 10Y
Carl Zeiss Meditec AG
XETRA:AFX
Inventory
€536.6m
CAGR 3-Years
23%
CAGR 5-Years
15%
CAGR 10-Years
11%
Stratec SE
XETRA:SBS
Inventory
€149m
CAGR 3-Years
21%
CAGR 5-Years
20%
CAGR 10-Years
22%
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
Inventory
€45.6m
CAGR 3-Years
4%
CAGR 5-Years
8%
CAGR 10-Years
7%
Siemens Healthineers AG
XETRA:SHL
Inventory
€4.6B
CAGR 3-Years
11%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Draegerwerk AG & Co KGaA
XETRA:DRW8
Inventory
€747.8m
CAGR 3-Years
3%
CAGR 5-Years
6%
CAGR 10-Years
5%
Sartorius AG
XETRA:SRT
Inventory
€788.5m
CAGR 3-Years
-4%
CAGR 5-Years
14%
CAGR 10-Years
18%

Carl Zeiss Meditec AG
Glance View

Economic Moat
None
Market Cap
4.4B EUR
Industry
Health Care

Carl Zeiss Meditec AG stands as a beacon in the realm of medical technology, carving a niche through its innovative solutions in ophthalmology and microsurgery. Rooted in the prestigious legacy of the Zeiss Group, this company seamlessly fuses cutting-edge technology with practical medical applications. Its headquarters in Jena, Germany, serve as the crucible for pioneering research and development endeavors, channeling expertise into products that enhance both diagnostic and surgical capabilities. The heart of its operations revolves around creating technological marvels such as optical coherence tomography (OCT) instruments and surgical microscopes, which bring precision and enhanced clarity to the medical field. Through a well-executed blend of R&D and strategic acquisitions, Carl Zeiss Meditec consistently remains at the forefront of medical innovation, ensuring it meets the ever-evolving needs of the healthcare sector. Financially, the company thrives by selling its sophisticated medical devices directly to healthcare professionals, hospitals, and clinics worldwide. Rather than merely creating instruments, Carl Zeiss Meditec's business model is deeply entwined with providing comprehensive workflow solutions and service support, ensuring that medical practitioners extract maximum utility from their investments. By offering not just products but also extensive after-sales service and maintenance, the company builds sustained relationships with its clients, fostering a cycle of trust and repeat business. In addition, its engagement in training and support services enhances user competencies, ensuring the seamless integration of its technology into everyday medical practice and underscoring its commitment to elevating healthcare standards globally. Through this multifaceted approach, Carl Zeiss Meditec solidifies its position as an indispensable ally in the medical community, both as a supplier of state-of-the-art equipment and as a provider of essential healthcare solutions.

AFX Intrinsic Value
79.73 EUR
Undervaluation 37%
Intrinsic Value
Price

See Also

What is Carl Zeiss Meditec AG's Inventory?
Inventory
536.6m EUR

Based on the financial report for Dec 31, 2024, Carl Zeiss Meditec AG's Inventory amounts to 536.6m EUR.

What is Carl Zeiss Meditec AG's Inventory growth rate?
Inventory CAGR 10Y
11%

Over the last year, the Inventory growth was 3%. The average annual Inventory growth rates for Carl Zeiss Meditec AG have been 23% over the past three years , 15% over the past five years , and 11% over the past ten years .

Back to Top